Newly developed nanobodies could eventually be used to treat neurocognitive disorders

The research, published July 19 in Nature Communications, was a collaboration between Johns Hopkins Medicine researchers, led by Xiaobo Mao, Ph.D., and scientists at the University of Michigan, Ann Arbor.